| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.45 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |